Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Full stop
doi: 10.1177/1060028016673072
The combination results in three convergent signals: reduced caloric intake (GLP-1/GIP appetite suppression), improved insulin sensitivity (GIP/GLP-1 pancreatic effects), and elevated calorie burn (glucagon thermogenesis)
Immediate medical attention is warranted for: Severe diarrhea (more than 6-8 watery stools daily) Blood or mucus in stools Severe abdominal pain or cramping Severe abdominal pain radiating to the back (possible pancreatitis) Upper right abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Signs of dehydration (extreme thirst, dark urine, dizziness, confusion) Fever above 101F (38.3C) Unintentional weight loss exceeding expected therapeutic effects Inability to maintain adequate oral fluid intake Healthcare providers should evaluate for potential complications including electrolyte disturbances (hypokalemia, hyponatremia), acute kidney injury from volume depletion, or concurrent gastrointestinal conditions
